ArticleCureus2024

Ibrutinib as a Secondary Treatment for Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease: A Case Series of 11 Patients During the COVID-19 Era.

Yo Mizutani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.